<code id='68F8E54827'></code><style id='68F8E54827'></style>
    • <acronym id='68F8E54827'></acronym>
      <center id='68F8E54827'><center id='68F8E54827'><tfoot id='68F8E54827'></tfoot></center><abbr id='68F8E54827'><dir id='68F8E54827'><tfoot id='68F8E54827'></tfoot><noframes id='68F8E54827'>

    • <optgroup id='68F8E54827'><strike id='68F8E54827'><sup id='68F8E54827'></sup></strike><code id='68F8E54827'></code></optgroup>
        1. <b id='68F8E54827'><label id='68F8E54827'><select id='68F8E54827'><dt id='68F8E54827'><span id='68F8E54827'></span></dt></select></label></b><u id='68F8E54827'></u>
          <i id='68F8E54827'><strike id='68F8E54827'><tt id='68F8E54827'><pre id='68F8E54827'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:1652
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Testing for cancer recurrence creates a new limbo for patients
          Testing for cancer recurrence creates a new limbo for patients

          EssayauthorMaraBuchbinderandherhusband,Jesse(right).CourtesyMaraBuchbinderMyhusband’scancercamebackt

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Medtronic CEO on promising devices for diabetes, hypertension

          GeoffMartha,CEOofMedtronicCourtesyMedtronicAsoneofthelargestandoldestmedicaldevicecompaniesintheworl